Page 4 - Cell Therapies News Today : Breaking News, Live Updates & Top Stories | Vimarsana

DBV Technologies Reports First Quarter 2024 Financial Results and Business Update

DBV Technologies Reports First Quarter 2024 Financial Results and Business Update
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomFrance generalKatie matthewsRobert pietruskoAurora krauseSmithkline beechamPharis mohideenViropharma incorporatedAmerican society of geneRegulatory affairsGlobal regulatory affairsResearch developmentHealth scienceExchange commissionMillennium pharmaceuticals

DBV Technologies S A : DBV Technologies Reports First Quarter 2024 Financial Results and Business Update

DBV Technologies S A : DBV Technologies Reports First Quarter 2024 Financial Results and Business Update
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

France generalUnited kingdomUnited statesAurora krauseSmithkline beechamRobert pietruskoXand linkedinKatie matthewsZwei rohstoff chancenExperte carsten storkPharis mohideenMillennium pharmaceuticalsResearch developmentRegulatory affairsCompany adssAmerican society of gene

Nanoscope Therapeutics Announces Presentations at the ARVO Annual Meeting

/PRNewswire/ Nanoscope Therapeutics Inc., a late-stage clinical biotechnology company developing gene therapies for retinal degenerative diseases, today.

United statesSubrata batabyalNajam sharifVinitb mahajanSamarendra mohantySamuel baroneNanoscope therapeutics incPrnewswire nanoscope therapeutics incProfessor of ophthalmology at stanford universitySeattle convention centerClinical developmentGlobal researchTherapeutics incMulti characteristic opsinNanoscope therapeuticsConvention center

The murky, unregulated world of anti-ageing stem cell therapy

Stem cells are the new focal point of the rich and famous with Hollywood A-listers reportedly spending tens of thousands of pounds each year on expensive therapies offered by private longevity clinics which promise to regenerate the ageing body.

United statesUnited kingdomCristiano ronaldoJon framptonDarius wideraJohn cleeseUniversity of readingUniversity of birminghamHollywooda listersProf framptonRafael nadalStem cell therapyAdult stem cellsStem cellsPluripotent stem cellsStem cell transplant

Bristol Myers signs $380 million CAR-T therapies supply deal with Cellares

Drugmaker Bristol Myers Squibb said it has signed a $380 million deal with contract manufacturer Cellares to manufacture its CAR-T cell therapies in the United States, EU and Japan. The collaboration will help Bristol Myers to expand its manufacturing capacity due to increasing demand. The company said in February it was looking to launch both its CAR-T blood cancer therapies Abecma and Breyanzi in a number of new countries this year.

United statesBristol myersBristol myers squibbShinjini ganguliChristy santhoshDrugmaker bristol myers squibbCell therapiesContract manufacturer